Acrux Limited

17 articles about Acrux Limited

• Acrux Plunges After Deal With Eli Lilly Is Terminated

  9/6/2017

• Eli Lilly and Company Pays Acrux Limited $87M on FDA Approval of Testosterone Replacement Therapy

  11/24/2010

• Eli Lilly and Company (JOBS) Gets Rights to Sell Testosterone Drug from Acrux Limited in Deal Worth up to $335 Million

  3/16/2010

• Acrux Limited Announces Successful AXIRON Phase III Trial Results; Trial Met Primary Endpoint

  9/30/2009

• KV Pharmaceutical Company Signs Expanded Worldwide Partnership With Acrux Limited, Including the Development of Six New Branded Products

  8/12/2008

• Acrux Limited to Push on with Phase 3 Testosterone Trial

  7/18/2007

• Acrux Limited Completes $22.5 Million Capital Raising

  7/18/2007

• Acrux Limited Announces Positive Clinical Trial Results with Combination Contraceptive Sprays

  7/3/2007

• Acrux Limited and Organon to Develop Contraceptive Sprays

  3/1/2007

• Acrux Limited To Start USA Trial Of Its Unique Testosterone Lotion For Men

  9/18/2006

• Acrux Limited Awarded 1st European Patent

  4/19/2006

• Acrux Limited Acquires Rights To Commercialize World's First Contraceptive Spray

  2/14/2006

• Acrux Limited's Igor Gonda And Nina Wilkins Join Experts On Pain And Reproductive Health Panels At Biotechnology Industry Organization (BIO) CEO

  2/8/2006

• Acrux DDS Terminates Napa Biosciences License

  11/8/2005

• Acrux Reports Progress In Development Of Testosterone MD-Lotion(R) For Men

  9/7/2005

• Women: Orgasm In A Spray Undergoes Successfull Trials

  2/10/2005

• Acrux Hopes Sex Drug Spray Will Arouse Investors

  9/14/2004